Zdrowie i gospodarka · 08/02/2013

FDA Releases Draft Guidance for Industry on Alzheimer's Disease Treatment

The Food and Drug Administration (FDA) has made available a draft guidance document outlining its approach to evaluating the efficacy of drugs for treating early-stage Alzheimer's disease, a condition that occurs before the onset of dementia.